Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone for PTSD in Iraq/Afghanistan-era Veterans
NCT03799562Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2019
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregnenolone in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Jun 2019; status: completed.
02
Drugs
pregnenolone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03799562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799562.